About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Opinion on Therapeutic Targets
›
top-articles
Expert Opinion on Therapeutic Targets
4.5
(top 10%)
impact factor
2.0K
(top 10%)
papers
73.2K
(top 5%)
citations
104
(top 5%)
h
-index
4.9
(top 5%)
impact factor
2.4K
all documents
77.6K
doc citations
147
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
740
2
Targeting the EGFR signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
688
3
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Expert Opinion on Therapeutic Targets
2012
580
4
Targeting selectins and selectin ligands in inflammation and cancer
Expert Opinion on Therapeutic Targets
2007
323
5
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Expert Opinion on Therapeutic Targets
2007
314
6
The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy
Expert Opinion on Therapeutic Targets
2010
314
7
Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase
Expert Opinion on Therapeutic Targets
2012
290
8
Cathepsin B as a cancer target
Expert Opinion on Therapeutic Targets
2013
280
9
STAT proteins as novel targets for cancer drug discovery
Expert Opinion on Therapeutic Targets
2004
268
10
Targeting the dopamine D2receptor in schizophrenia
Expert Opinion on Therapeutic Targets
2006
265
11
The paraventricular nucleus of the hypothalamus – a potential target for integrative treatment of autonomic dysfunction
Expert Opinion on Therapeutic Targets
2008
249
12
The role of dopamine in motivation for food in humans: implications for obesity
Expert Opinion on Therapeutic Targets
2002
241
13
MERS-CoV spike protein: a key target for antivirals
Expert Opinion on Therapeutic Targets
2017
236
14
Targeting CCL5 in inflammation
Expert Opinion on Therapeutic Targets
2013
234
15
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Expert Opinion on Therapeutic Targets
2018
225
16
The 5-HT3receptor as a therapeutic target
Expert Opinion on Therapeutic Targets
2007
217
17
From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer
Expert Opinion on Therapeutic Targets
2006
216
18
Targeting the Bcl-2 family for cancer therapy
Expert Opinion on Therapeutic Targets
2013
213
19
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
Expert Opinion on Therapeutic Targets
2011
209
20
Wnt signaling as a therapeutic target for bone diseases
Expert Opinion on Therapeutic Targets
2009
205
21
Tyrosine kinases as targets in cancer therapy – successes and failures
Expert Opinion on Therapeutic Targets
2003
200
22
Inhibiting the transcription factor HSF1 as an anticancer strategy
Expert Opinion on Therapeutic Targets
2009
198
23
The potential of targeting Wnt/β-catenin in colon cancer
Expert Opinion on Therapeutic Targets
2014
198
24
Targeting the HGF/Met signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
197
25
Overcoming drug resistance in pancreatic cancer
Expert Opinion on Therapeutic Targets
2011
194
26
Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain
Expert Opinion on Therapeutic Targets
2017
192
27
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Expert Opinion on Therapeutic Targets
2011
187
28
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Expert Opinion on Therapeutic Targets
2017
185
29
Targeting TGF-β signaling in cancer
Expert Opinion on Therapeutic Targets
2013
183
30
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate
Expert Opinion on Therapeutic Targets
2010
178
31
Targeting the PI3K signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
176
32
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Expert Opinion on Therapeutic Targets
2015
174
33
CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects
Expert Opinion on Therapeutic Targets
2003
172
34
Targeting acetylcholinesterase to treat neurodegeneration
Expert Opinion on Therapeutic Targets
2007
172
35
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Expert Opinion on Therapeutic Targets
2019
170
36
Na
v
1.7 and other voltage-gated sodium channels as drug targets for pain relief
Expert Opinion on Therapeutic Targets
2016
168
37
Targeting the Wnt/β-catenin signaling pathway in human cancers
Expert Opinion on Therapeutic Targets
2011
164
38
Grb2 signaling in cell motility and cancer
Expert Opinion on Therapeutic Targets
2008
162
39
GLUT1 as a therapeutic target in hepatocellular carcinoma
Expert Opinion on Therapeutic Targets
2009
162
40
Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Expert Opinion on Therapeutic Targets
2012
162
41
VEGF as a potential target in lung cancer
Expert Opinion on Therapeutic Targets
2017
159
42
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
Expert Opinion on Therapeutic Targets
2013
158
43
Targeting the ubiquitin–proteasome system for cancer therapy
Expert Opinion on Therapeutic Targets
2013
157
44
NF-κB as a therapeutic target in neurodegenerative diseases
Expert Opinion on Therapeutic Targets
2007
155
45
Stathmin: a protein with many tasks. New biomarker and potential target in cancer
Expert Opinion on Therapeutic Targets
2011
155
46
Targeting survivin in cancer therapy
Expert Opinion on Therapeutic Targets
2008
154
47
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
Expert Opinion on Therapeutic Targets
2007
153
48
Targeting the Nrf2 pathway against cardiovascular disease
Expert Opinion on Therapeutic Targets
2009
153
49
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Expert Opinion on Therapeutic Targets
2011
150
50
TRAIL in cancer therapy: present and future challenges
Expert Opinion on Therapeutic Targets
2007
148
site/software ©
exaly
; All materials licenced under
CC by-SA
.